Drugmaker Mallinckrodt Weighs 2nd Bankruptcy As $200M Opioid Payment Comes Due

(June 13, 2023, 3:12 PM EDT) -- DUBLIN, Ireland — Drugmaker Mallinckrodt PLC has told its shareholders that it has received unsolicited letters from creditors asking the company to evaluate its “financial wherewithal and consider alternative options to meet its financial responsibilities, including, in the case of certain Holders, consideration of alternatives to making the $200 million payment required by the Company’s opioid settlement to be made to the Opioid Master Disbursement Trust II” on June 16....

Attached Documents

Related Sections